CryoTherapeutics, a Germany-based developer of treatments for cardiovascular disease, has attracted €5.2m ($5.7m) in series B capital from a consortium featuring public-private investment partnership High-Tech Gruenderfonds (HTGF).
The round was led by Creathor Venture, a venture capital firm backed by various vehicles of the European Investment Fund, part of multilateral of financial institution EIB Group.
Germany’s federal development bank KfW and its North Rhine-Westphalia peer NRW.Bank also contributed capital to the round alongside Peppermint Venture Partners, Getz Brothers and assorted…
